Back to today’s briefing

Story perspectives

GLP-1 Weight Loss Drugs Linked to Eye Risks

8/13/2025

37 6

Summary

Story summary

GLP-1 agonists, popular for weight loss and diabetes control, have been linked to a heightened risk of severe eye issues, particularly NAION, a rare optic nerve disorder. Recent research indicates a modest risk of NAION and a slight rise in diabetic retinopathy. Patients are urged to prioritize regular eye exams and make informed choices about their treatment.

1 of 1

Story summary

GLP-1 agonists, popular for weight loss and diabetes control, have been linked to a heightened risk of severe eye issues, particularly NAION, a rare optic nerve disorder. Recent research indicates a modest risk of NAION and a slight rise in diabetic retinopathy. Patients are urged to prioritize regular eye exams and make informed choices about their treatment.